Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
SHILPAMED.NS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Sales Growth
YoY
Current
Estimates
Return on Equity
QoQ
Institutionnal Ownership
Q4.22
N/A
-0.76
vs 1.13
Q1.23
N/A
-0.93
vs 3.4
Q2.23
+40%
0.14
vs 0.1
Q3.23
+109%
0.19
vs -2.15
Q4.23
+170%
0.53
vs -0.76
Q1.24
+404%
2.82
vs -0.93
Q2.24
+943%
1.46
vs 0.14
Q3.24
+863%
1.83
vs 0.19
Q4.24
+513%
3.25
vs 0.53
Q1.25
+109%
5.9
vs 2.82
Q4.22
-4%
2.6B vs 2.7B
Q1.23
-23%
2.6B vs 3.4B
Q2.23
0%
2.6B vs 2.6B
Q3.23
+19%
3.1B vs 2.6B
Q4.23
+9%
2.9B vs 2.6B
Q1.24
+10%
2.9B vs 2.6B
Q2.24
+12%
2.9B vs 2.6B
Q3.24
+10%
3.4B vs 3.1B
Q4.24
+11%
3.2B vs 2.9B
Q1.25
+35%
3.9B vs 2.9B
Q1.23
0%
-0.00
vs -0.00
Q2.23
+0%
0
vs -0.00
Q3.23
+0%
0
vs 0
Q4.23
+0%
0
vs 0
Q1.24
+1%
0.01
vs 0
Q2.24
+1%
0.01
vs 0.01
Q3.24
+1%
0.01
vs 0.01
Q4.24
NA
NA
vs 0.01
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Relative Strength
SHILPAMED.NS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How SHILPAMED.NS compares to sector?
SHILPAMED.NS
102x